Bayer AG gained some protection for its OTC naproxen brands in both the US and in Mexico as a federal court upheld a US Patent and Trademark Office board's ruling that a competitor's US trademark for a product marketed to Hispanic consumers too closely resembled one Bayer has for a similar product in Mexico.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?